Back

Interaction of statin therapy to angiotensin ii receptor type 1 blockers in erectile dysfunction patients. effect on endothelial function and aortic stiffness

26 August 2018 (15:50 - 16:40)
Organised by:
Congress Presentation Part of: Optimal surrogate endpoints of drug response Angiotensin-Renin-Bradykinin System ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Nikolaos Ioakeimidis

University of Athens, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy
Doctor K. Tsuchida (Niigata, JP)
Abstract Slides
Presentation thumbnail
Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics
Doctor J. Leeds (South San Francisco, US)
Abstract Slides
Presentation thumbnail
Acute and chronic effect of ticagrelor versus clopidogrel on aortic stiffness
Associate Professor C. Vlachopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Cilostazol induces regression of carotid plaque in patients with high cardiovascular risk: CLOVER study. A multicenter, randomized trial.
Professor K. Cho (Busan, KR)
Abstract Slides
Presentation thumbnail
Ticagrelor reduced CD40L level in patient with ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention compared with clopidogrel
Doctor Z. Li (Jinan, CN)
Abstract Slides

Access the full session

Session thumbnail
Optimal surrogate endpoints of drug response

The Event

Event poster

ESC Congress 2018

26 August 2018 15:50 CET
You may be interested in
thumbnail
Congress Presentation
RNA therapeutics for treatment of hypertension
thumbnail
Congress Presentation
Bradycardic effect of endothelial-specific bradykinin type-II receptors overexpression in mice: impact on blood pressure.
thumbnail
Congress Session
Hypertension with cardiometabolic comorbidities: which drugs to select and which to avoid

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources